Table 3 Clinical outcomes according to the tertile and quartile of the soluble neprilysin level
| Â | Neprilysin | Log rank, P value | |||
<  56.3 pg/ml (n = 228) | 56.3–111.4 pg/ml (n = 235) | >  111.4 pg/ml (n = 231) | |||
All-cause death | 15 (6.5%) | 13 (5.6%) | 20 (8.7%) | 0.410 | |
MACE | 11 (4.8%) | 15 (6.5%) | 17 (7.4%) | 0.470 | |
| Â | Neprilysin | Log rank, P value | |||
<  46.8 pg/ml (n = 173) | 46.8–76.0 pg/ml (n = 175) | 76.0–133.9 pg/ml (n = 173) | >  133.9 pg/ml (n = 173) | ||
All-cause death | 11 (6.4%) | 9 (5.1%) | 12 (6.9%) | 16 (9.2%) | 0.482 |
MACE | 8 (4.6%) | 11 (6.3%) | 12 (6.9%) | 12 (6.9%) | 0.760 |